Our mission is to accelerate proof of efficacy of drug candidates in human tumours by translational research approaches, and to contribute to the identification of biomarkers allowing the prediction of patient responses to drugs, first step to personalized medicine.
We work closely with our sponsors to help them to select the relevant PDX tumor models for their pharmacological assays, according to:
  • PDX clinical patient data;
  • PDX tumor growth;
  • PDX molecular data;
  • PDX pharmacology profile.